Harbour Investments’s Sanara MedTech SMTI Stock Holding History

Harbour Investments’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.4K	Hold	4,000	–	–	﹤0.01%	2038
2026 Q1	$68.7K	Buy	+4,000	New	+$82.3K	﹤0.01%	2163
2021 Q4	–	Sell	-8,000	Closed	-$274K	–	3540
2021 Q3	$274K	Hold	8,000	–	–	0.01%	869
2021 Q2	$296K	Hold	8,000	–	–	0.01%	872
2021 Q1	$249K	Buy	+8,000	New	+$277K	0.01%	879

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Harbour Investments's SMTI Position: Q2 2026 in Review

Harbour Investments held its Sanara MedTech (SMTI) position steady in Q2 2026 at 4,000 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

Harbour Investments first reported a position in SMTI in Q1 2021 and has held it in 5 quarters since. The position peaked at $296K in Q2 2021. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Harbour Investments held 4,000 shares of Sanara MedTech worth $94.4K as of Q2 2026.
Harbour Investments left its Sanara MedTech share count unchanged in Q2 2026.
Sanara MedTech made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #2038 holding.
Harbour Investments first reported a position in Sanara MedTech in Q1 2021 and has held it in 5 quarters since.
Harbour Investments's Sanara MedTech position peaked at $296K in Q2 2021.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.